New Directions and Practice Impacting Recommendations in Multiple Sclerosis
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NeurologyLive® Brain Games: November 2, 2025
2
Designing the Phase 3 EMPEROR Trial and Future Considerations
3
Efgartigimod Effective in Seronegative gMG, Obexelimab Meets Primary End Point, FDA Accepts NDA for Tau Tracer MK-6240
4
AI in MS: IJMSC Survey Results
5
